Monitoring of human endometrial function by radioimmunoassay of PEP

Claim 2

A radioimmunoassay method for the quantitative determination of PEP in a body fluid comprising: (a) partially purifying PEP chromatographically; (b) radioisotopically labelling said partially purified PEP and further purifying it chromatographically; (c) preparing an antibody specific against PEP using said partially purified PEP as an antigen; (d) admixing a sample of the body fluid suspected of containing PEP with radioisotope labeled PEP and said antibody against PEP; (e) incubating said mixture for a time sufficient to allow unlabeled PEP and radioisotope labeled PEP to competitively bind on said antibody against PEP; (f) separating from said mixture antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP; (g) measuring the radioactivity of the separated antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP; measuring the radioactivity of the mixture from which the antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP was separated; or measuring the radioactivity of both the antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP and the mixture from which it was separated to determine the content of PEP in said body fluid.

Claim 3

The method of claim 1 wherein said body fluid is serum.

Claim 4

The method of claim 1 wherein said body fluid is amniotic fluid.

Claim 5

The method of claim 1 wherein said body fluid is endometrial fluid.

Claim 6

The method of claim 1 wherein said radioisotope is selected from the group consisting of 125 I, and 131 I.

Claim 7

The method of claim 1 wherein said radioisotope is 125 I.

Claim 8

The method of claim 1 wherein said antibody is derived from goat.

Claim 9

The method of claim 1 wherein said antibody containing bound unlabeled PEP and radioisotope-labeled PEP is separated from said mixture by precipitation of said bound antibody and removal of said precipitate from said mixture.

Claim 10

The method of claim 8 wherein said precipitate is effected by inclusion in said mixture of body fluid sample, unlabeled PEP, radioisotope labeled PEP and a second antibody which is an antibody against said first antibody but is not an antibody against PEP, said antibody forming a precipitate upon binding with said first antibody to which is bound unlabeled and labeled PEP.

Claim 11

The method of claim 9 wherein said second antibody is derived from an animal species other than that from which the first antibody is derived.

Claim 12

The method of claim 10 wherein said first antibody is goat antibody and said second antibody is rabbit anti-goat antibody.

Claim 13

The method of claim 1 wherein the radioactivity of the separated antibody against PEP to which is bound unlabeled and radioisotope labeled PEP is measured to determine the content of PEP in said body fluid sample.

Claim 14

The method of claim 1 wherein the content of PEP in said body fluid sample is determined by comparison of said measured radioactivity with a dose-response curve plotted from the results of the radioimmunoassay method of claim 1, employing as body fluid samples, aqueous solutions containing known amounts of PEP, partially purified according to the method of claim 1.

Claim 15

A composition of matter adapted for use in a radioimmunoassay method for the quantitative determination of PEP in a body fluid comprising PEP labeled with a radioactive isotope, prepared according to the method of claim 1.

Claim 16

The composition of claim 14 wherein said radioactive isotope is selected from the group consisting of 125 I and 131 I.

Claim 17

The composition of claim 14 wherein said radioisotope is 125 I.

Claim 18

The composition of claim 14 wherein said radioisotope is linked to said PEP through the tyrosyl moiety thereof.

Claim 19

A composition in kit form adapted for radioimmunoassay of a body fluid to determine the PEP content thereof comprising, in separate packages: (1) a radioisotope-labeled PEP and (2) an antibody against PEP, each prepared according to the method of claim 1.

Claim 20

The composition in kit form of claim 18 additionally containing, in separately packaged form: (3) a second antibody against said antibody against PEP of claim 18 and (4) a series of unlabeled PEP solutions, partially purified according to the method of claim 1, for use as reference standards in said radioimmunoassay.

Claim 21

The composition of claim 18 wherein said radioisotope is selected from the group consisting of 125 I and 131 I.

Claim 22

The composition of claim 18 wherein said radioisotope is 125 I.

Claim 23

The composition of claim 18 wherein said antibody against PEP is derived from goat.

Claim 24

The composition of claim 19 wherein said antibody against PEP is derived from goat and said second antibody against said antibody against PEP is derived from rabbit.

Claim 25

In a method for diagnosing conditions of the human body which affect the production or maintenance of the level of progesterone in the endometrium, the improvement comprising determining the content of PEP in a body fluid of the human by a radioimmunoassay comprising: (a) partially purifying PEP chromatographically; (b) radioisotopically labeling said partially purified PEP and further purifying it chromatographically; (c) preparing an antibody specific against PEP using said partially purified PEP as an antigen; (d) admixing a sample of the body fluid, radioisotope labeled PEP and said antibody against PEP; (e) incubating said mixture for a time sufficient to allow unlabeled PEP and radioisotope labeled PEP to competitively bind said antibody against PEP; (f) separating from said mixture antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP; and (g) measuring the radioactivity of the separated antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP measuring the radioactivity of the mixture from which said antibody against PEP was separated, or measuring the radioactivity of both the separated antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP and the mixture from which it was separated to determine the content of PEP in said body fluid; and further ascertaining therefrom the level of progesterone in the endometrium.

Claim 26

In a method for diagnosing conditions of the human body which affect the production or maintenance of the level of progesterone in the endometrium, the improvement comprising determining the content of PEP in a body fluid of the human by a radioimmunoassay comprising: (a) partially purifying PEP chromatographically; (b) radioisotopically labeling said partially purified PEP and further purifying it chromatographically; (c) preparing an antibody specific against PEP using said partially purified PEP as an antigen; (d) admixing a sample of the body fluid, radioisotope labeled PEP and said antibody against PEP; (e) incubating said mixture for a time sufficient to allow unlabeled PEP and radioisotope labeled PEP to competitively bind said antibody against PEP; (f) separating from said mixture antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP; and (g) measuring the radioactivity of the separated antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP measuring the radioactivity of the mixture from which said antibody against PEP was separated, or measuring the radioactivity of both the separated antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP and the mixture from which it was separated to determine the content of PEP in said body fluid; and further ascertaining therefrom the level of progesterone in the endometrium.

Claim 27

The method of claim 24 wherein said body fluid is serum.

Claim 28

The method of claim 24 wherein said body fluid is amniotic fluid.

Claim 29

The method of claim 24 wherein said body fluid is endometrial fluid.

Claim 30

The method of claim 24 wherein said radioisotope is selected from the group consisting of 125 I and 131 I.

Claim 31

The method of claim 24 wherein said radioisotope is 125 I.

Claim 32

The method of claim 24 wherein said antibody is derived from goat.

Claim 33

The method of claim 24 wherein said antibody against PEP to which is bound unlabeled PEP and radioisotope labeled PEP is separated from said mixture by precipitation of said bound antibody and removal of said precipitate from said mixture.

Claim 34

The method of claim 31 wherein said precipitation is effected by inclusion in said mixture of body fluid sample, unlabeled PEP and radioisotope-labeled PEP a second antibody which is an antibody against said first antibody but is not an antibody against PEP, said second antibody forming a precipitate upon binding with said first antibody to which is bound unlabeled- and labeled-PEP.

Claim 35

The method of claim 32 wherein said second antibody is derived from an animal species other than that from which the first antibody is derived.

Claim 36

The method of claim 33 wherein said first antibody is goat antibody and said second antibody is rabbit anti-goat antibody.

Claim 37

The method of claim 24 wherein the radioactivity of the separated antibody containing bound unlabeled- and radioisotope-labeled-PEP is measured to determine the content of PEP in said body fluid sample.

Claim 38

The method of claim 24 wherein the content of PEP in said body fluid is determined by comparison of said measured radioactivity with a dose response curve plotted from the results of the radioimmunoassay methods of claim 25 employing as body fluid samples, aqueous solution containing known amounts of said partially purified PEP.

Claim 39

The method of claim 1 wherein the assay is carried out under non-equilibrium conditions.